Cardiothoracic Surgeon Warns FDA, Pfizer on Immunological Danger of COVID Vaccines in Recently Convalescent and Asymptomatic Carriers

Cardiothoracic Surgeon requests delay of immunization in any recently convalescent patients

Dr. Hooman Noorchashm says FDA, Pfizer and Moderna must consider the danger COVID vaccines pose to the recently convalescent or asymptomatic carriers of SARS-CoV-2 — especially the elderly, frail or anyone with significant cardiovascular risk factors.